| # | Drug | Count |
|---|---|---|
| 0 | APIXABAN | 1 |
| 1 | AXICABTAGENE CILOLEUCEL | 1 |
| 2 | CYCLOSPORINE | 1 |
| 3 | FIBRINOGEN HUMAN | 1 |
| 4 | HUMAN IMMUNOGLOBULIN G | 1 |
| 5 | METHYLPREDNISOLONE | 1 |
| 6 | MYCOPHENOLATE MOFETIL | 1 |
| 7 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 1 |
| 8 | NIVOLUMAB | 1 |
| 9 | RITUXIMAB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FIBRINOGEN HUMAN | 1 | 0.0043 |
| 1 | AXICABTAGENE CILOLEUCEL | 1 | 0.0001 |
| 2 | HUMAN IMMUNOGLOBULIN G | 1 | 0.0000 |
| 3 | APIXABAN | 1 | 0.0000 |
| 4 | UPADACITINIB | 1 | 0.0000 |
| 5 | NIVOLUMAB | 1 | 0.0000 |
| 6 | USTEKINUMAB | 1 | 0.0000 |
| 7 | CYCLOSPORINE | 1 | 0.0000 |
| 8 | TACROLIMUS OINTMENT 0.1% | 1 | 0.0000 |
| 9 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 1 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 2 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 4 | Interleukin-12 Antagonist [EPC] | 1 | 0.0000 |
| 5 | Interleukin-23 Antagonist [EPC] | 1 | 0.0000 |
| 6 | Calcineurin Inhibitor Immunosuppressant [EPC] | 1 | 0.0000 |
| 7 | Janus Kinase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Factor Xa Inhibitor [EPC] | 1 | 0.0000 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |